Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial by Monk, Bradley J, Prof, Toita, Takafumi, MD, Wu, Xiaohua, Prof, Vázquez Limón, Juan C, MD, Tarnawski, Rafal, Prof, Mandai, Masaki, Prof, Shapira-Frommer, Ronnie, MD, Mahantshetty, Umesh, Prof, del Pilar Estevez-Diz, Maria, Prof, Zhou, Qi, Prof, Limaye, Sewanti, MD, Godinez, Francisco J Ramirez, MD, Oppermann Kussler, Christina, MD, Varga, Szilvia, MD, Valdiviezo, Natalia, MD, Aoki, Daisuke, Prof, Leiva, Manuel, MD, Lee, Jung-Yun, Prof, Sulay, Raymond, MD, Kreynina, Yulia, MD, Cheng, Wen-Fang, Prof, Rey, Felipe, MD, Rong, Yi, PhD, Ke, Guihao, Prof, Wildsmith, Sophie, PhD, Lloyd, Andrew, BSc, Dry, Hannah, BS, Tablante Nunes, Ana, MD, Mayadev, Jyoti, Prof

Get full text